Law Lawsuits

  • Sean Egan on Potential SEC Charges

    Sean Egan, Egan-Jones Ratings Co. president, discusses potential charges by the SEC against his company. The regulator is looking at whether the Egan-Jones made intentionally-false statements when it applied to become a nationally-recognized ratings agency in 2007.

  • Google vs. Oracle: Page Testifies

    CNBC's Jon Fortt reports on the latest details on the trial between Oracle and Google.

  • NYSE traders

    U.S. securities regulators on Wednesday finalized long-awaited rules that will dictate which companies dealing in derivatives will be subject to costly capital, margin and business conduct requirements.

  • Oracle CEO Ellison Testifies

    CNBC's Jon Fortt reports on Oracle building a case that Google really did need a license to use specific parts of the company's Java software. The FMHR traders discuss.

  • woman-in-wheelchair-200.jpg

    A small cadre of lawyers, some from out of state, are using New York City’s age and architectural quirkiness as the foundation for a flood of lawsuits citing violations of the Americans With Disabilities Act.

  • Google-Oracle Trial Begins

    The jury selection in a dispute over smartphone technology between Google and Oracle starts today. CNBC's Jon Fortt reports.

  • Dennis Kozlowski

    Imprisoned Ex-Tyco CEO Dennis Kozlowski begged for mercy from a parole board last week, before learning later that his plea had been rejected, a newly-released transcript of the proceeding showed Wednesday, USA Today reports.

  • Remington Guns

    Millions of Americans hunt, but it is fair to say none of them expect what happened to Justen Yerger of Monroe, Louisiana.

  • Apple's Antitrust Case

    CNBC's Hampton Pearson offers insight on the government's lawsuit against Apple.

  • Visitors try out various ebook readers on display.

    The U.S. government has filed an antitrust lawsuit against Apple and various electronic book publishers, claiming they conspired to raise prices and limit competition. 

  • American Apparel CEO Speaks

    One year ago, American Apparel was warning of a possible bankruptcy and facing a new round of sexual harassment allegations against its CEO. Have things changed? CNBC's Jane Wells spoke with Dov Charney, the company's CEO, to find out.

  • Nike Sues Reebok

    Nike's suit claims Reebok does not have license to use Tebow's name, with CNBC's Darren Rovell.

  • Rep. Neugebauer on MF Global Hearing

    A new panel of MF Global executives face lawmakers today. Insight with Rep. Randy Neugebauer, (R-TX).

  • 13-Year Sentence for Defense Contractor

    A defense contractor is sentenced to 13 years in prison for attempting to sell defense secrets, reports CNBC's Eamon Javers.

  • JPMorgan Chase Settles Suit for Defrauding Vets

    CNBC's Eamon Javers talks to two mortgage brokers who became millionaires after the settlement of a whistle-blower lawsuit against JPMorgan Chase. The company was said to be charging improper attorneys' fees to veterans in a VA home mortgage assistance program.

  • facebook_login_head_200.jpg

    Lawmakers and attorneys in at least two states are considering proposals that would require Facebook and other social networks to grant access to the pages of loved ones when a family member dies, essentially making the site contents part of a person's digital estate.

  • Citigroup Building

    A federal appeals court said Thursday that a judge likely overstepped his authority when he blocked a $285 million settlement over toxic mortgage securities after concluding that it was bad policy for a regulatory agency to accept a deal that does not include an admission of liability.

  • U.S. securities regulators took enforcement action against an online trading platform and two private funds offering Facebook shares on Wednesday, the first action in a year-long probe into the lightly regulated world of private company-share trading.

  • underpaid_name_tag_200.jpg

    Employers are offering fewer paid internships because of recent lawsuits, USA Today reports.

  • Novartis

    India’s mass production of generic versions of drugs patented elsewhere helps poor people with treatment that would otherwise be too costly, but drug companies say the knockoffs stifle innovation. The New York Times reports.